Drugs for Neglected Diseases initiative 211d ago

‘Any organization that works in R&D has a duty to have proper governance that includes peer review.’ Watch a conversation with Dr Pauline Williams CBE, FMedSci, the newly appointed chair of our Scientific Advisory Committee (SAC), in which she shares: 🔸 why the SAC’s scientific opinions are key to DNDi’s work 🔸 her views on non-profit medical R&D 🔸 current shifts in the global health innovation ecosystem 🔸 how organizations like DNDi can tackle future challenges Our SAC provides evidence-driven guidance to our Board of Directors on matters related to R&D and project selection. The SAC is fully independent and brings together scientists in drug discovery and development, alongside public health experts specializing in infectious diseases and neglected populations. All our R&D projects are reviewed by the SAC. Among other achievements in her remarkable career in drug development, Dr Williams was the Head of Global Health R&D at GSK, launched the GSK Africa Lab, and served as a member of the Medical Research Council of UK Research and Innovation. We warmly congratulate Dr Williams for joining our SAC and taking on this new and vital role. You can also listen to the audio version of this interview on our newly launched podcast channel: 👉 Spotify: https://open.spotify.com/episode/6A7Sgf6stAL4rY6IifQKCv?si=818ed191dbb0430b 👉 Apple Podcasts: https://podcasts.apple.com/us/podcast/ep-1-dr-pauline-williams-chair-of-dndi-scientific/id1855462999?i=1000738090970 Introductory music: Maputo Queen by Etienne de la Sayette. Reproduced with the kind permission of the artist. ----------------- The Drugs for Neglected Diseases initiative (DNDi) is an international non-profit developing safe, effective, and affordable treatments for the most neglected patients. https://dndi.org